Compare Aptiv PLC (APTV) vs Invesco Ltd. (IVZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aptiv PLC vs Invesco Ltd. — how do they compare? Aptiv PLC trades at $48.69 (market cap $10.30B), while Invesco Ltd. trades at $31.45 (market cap $13.85B). The key difference: Invesco Ltd. is the larger of the two by market cap, and Invesco Ltd. pays a 2.74% dividend while Aptiv PLC pays none. Which is the better fit depends on your goals.
| APTV | IVZ | |
|---|---|---|
Market Cap | $10.30B | $13.85B |
Sector | Consumer Cyclical | Financials |
52-Week High | $76.82 | $32.01 |
52-Week Low | $46.30 | $20.67 |
Enterprise Value | $15.23B | $24.01B |
Dividend Yield | — | 2.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
APTV trades at $48.38, down 2.87% on the day, reflecting bearish technical signals and recent guidance cuts. The stock shows strong valuation metrics with a P/E of 22.45 and P/S of 0.52, but profitability is weak with a net margin of 1.07%. Recent Q2 2026 earnings beat estimates, but the company lowered its full-year outlook due to China demand issues and launch delays, pressuring investor sentiment.
The outlook is mixed: low valuation and analyst consensus of $70.09 target suggest upside, but near-term execution risks and cash flow pressures create uncertainty. Investment opportunity hinges on margin recovery and China market stabilization, while risks include sustained guidance cuts and competitive pressures in automotive technology.
Invesco (IVZ) trades at $31.58, down 0.5% today but near its 52-week high, with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, with Q3 results pending. Revenue has grown to $6.38 billion in 2025, though net income remains negative. Analyst consensus is a $32.50 price target with a mix of Buy and Hold ratings, and the firm maintains a stable dividend payout.
The outlook for IVZ is cautiously optimistic, supported by strong assets under management and positive cash flow trends. However, profitability challenges and expense pressures pose risks. Upside potential hinges on earnings improvement and market sentiment, while downside risks include margin compression and competitive pressures in asset management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aptiv PLC
Aptiv's signal and power solutions segment supplies components and systems that make up a vehicle's electrical system backbone, including wiring assemblies and harnesses, connectors, electrical centers, and hybrid electrical systems. The advanced safety and user experience segment provides body controls, infotainment and connectivity systems, passive and active safety electronics, advanced driver-assist technologies, and displays, as well as the development of software for these systems. Aptiv's largest customer is General Motors at roughly 12% of 2021 revenue, including sales to GM's Shanghai joint venture, followed by Stellantis at 11%, and Volkswagen at 9%. North America and Europe represented approximately 38% and 33% of total 2019 revenue, respectively.
Read more on APTV →About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →
